Here you will find our latest news and updates.

July 2019 updates to website


The website has now been updated following July’s LMMG

The following drugs have been added/updated:

Brivaracetam — Adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adult, adolescents and children from 4 years of age with epilepsy

Stiripentol — Adjunctive therapy of refractory generalised tonic-clonic seizures in patients with severe myoclonic epilepsy in infancy (Dravet syndrome) in combination with clobazam and valproate (under expert supervision)

Ertugliflozin with metformin and a dipeptidyl peptidase‑4 inhibitor — Treating type 2 diabetes (NICE TA583)

Ocrelizumab — Treating Primary Progressive Multiple Sclerosis (NICE TA585)

Aliskiren — Essential hypertension

Minocycline — Susceptible infections

Bath & Shower Preparations — Dry & Pruritic Skin Conditions

Hormone Therapy — Gender Dysphoria

The following guidelines have been added/updated:

Trans-male and female Gender Dysphoria — Information Sheet — New

Camouflaging Products — Position Statement — New

Chronic Non-Cancer Pain — Guideline — Update

Testosterone — Shared Care — Update